Live
- Ten Arrested in Dacoity Case
- Egypt's new govt holds first meeting with focus on resolving power outage
- Chinese geologists unearth novel minerals at world's largest rare-earth mine
- NIA submits chargesheet in 2022 Bengal blast case
- Singapore authority seizes more than $6 million worth of vapes
- Slovak, Polish Presidents hail ties, discuss NATO Summit
- Pocso case: Bengaluru court summons former CM Yediyurappa on July 15
- Bangladesh PM Sheikh Hasina to visit China next week
- Another case filed in Bihar against Rahul Gandhi for remarks on Hindus
- JP Nadda to visit Jammu and Kashmir on July 6
Just In
Clinical trials underway on gene editing as potential therapy for sickle cell disease
![Clinical trials underway on gene editing as potential therapy for sickle cell disease Clinical trials underway on gene editing as potential therapy for sickle cell disease](https://assets.thehansindia.com/h-upload/2024/06/19/1455731-sickle-cell-disease.webp)
As traditional treatments such as blood transfusion, hydroxyurea, and other medicines have primarily focused on managing symptoms and preventing complications
New Delhi: As traditional treatments such as blood transfusion, hydroxyurea, and other medicines have primarily focused on managing symptoms and preventing complications, experts on World Sickle Cell Day on Wednesday said that recent advancements in sickle cell anaemia and innovations in medical technology have led to the development of several promising new therapies.
According to Dr Meet Kumar, Clinical Director, Haematology & Bone Marrow Transplant, Marengo Asia Hospitals, Gurugram, clinical trials carried out gene editing as a potential treatment method for sickle cell disease.
As per preliminary findings, normal haemoglobin production may be enabled, which could significantly reduce sickle cell disease symptoms and effects.
As per experts, in sickle cell disease, the blood can get too thick and clot, causing various brain problems like silent strokes, regular strokes (both where blood flow is blocked and where there is bleeding), and other issues. This happens because the thick blood can block the blood vessels in the brain.
"Silent cerebral infarcts occur in about 40 per cent of children by 18 years. Headaches occur in about 36 per cent of children with sickle cell anaemia. Ischemic stroke occurs in about 10 per cent of children, and hemorrhagic stroke occurs in children at a rate of about 3-10 per cent," Dr Praveen Gupta, Principal Director & Chief of Neurology, Fortis Hospital, told IANS.
Sickle cell disease may affect the brain in various ways, including cognitive dysfunctions like working memory, verbal learning, visual motor function, inadequacy in general intellectual functioning, problems with language and attention, as well as headaches, seizures, and others, the experts noted.
Dr Gaurav Kharya, Founder and Director, Cellogen Therapeutics, said that gene therapy represents one of the most promising advancements in the treatment of sickle cell disease. This approach involves modifying the patient's own hematopoietic stem cells to correct the genetic defect responsible for the disease. He further mentioned that the modified stem cells are "then reintroduced into the patient's body".
"Early clinical trials have shown promising results, with some patients achieving significant improvements in symptoms and quality of life," Kharya added.
![](/images/logo.png)
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com